Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peihao Chen

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Elife|August 18, 2020
Discovery of a molecular glue promoting CDK12-DDB1 interaction to trigger cyclin K degradationLu Lv, Peihao Chen, Longzhi Cao, et al.
The Journal of Biological Chemistry|October 10, 2019
A thiazole-derived oridonin analogue exhibits antitumor activity by directly and allosterically inhibiting STAT3Xiaofei Shen, Lin Zhao, Peihao Chen, et al.
Nature Communications|June 28, 2020
An alkaloid initiates phosphodiesterase 3A-schlafen 12 dependent apoptosis without affecting the phosphodiesterase activityYouwei Ai, Haibing He, Peihao Chen, et al.
Science Translational Medicine|April 22, 2026
Phase separation-based HTS identifies cobimetinib as a YAP-TEAD inhibitor that suppresses hyperactivated YAP-induced cancer progressionRuizeng Yang, Liqiao Hu, Jing Wang, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Elife|August 18, 2020
Discovery of a molecular glue promoting CDK12-DDB1 interaction to trigger cyclin K degradationLu Lv, Peihao Chen, Longzhi Cao, et al.
The Journal of Biological Chemistry|October 10, 2019
A thiazole-derived oridonin analogue exhibits antitumor activity by directly and allosterically inhibiting STAT3Xiaofei Shen, Lin Zhao, Peihao Chen, et al.
Nature Communications|June 28, 2020
An alkaloid initiates phosphodiesterase 3A-schlafen 12 dependent apoptosis without affecting the phosphodiesterase activityYouwei Ai, Haibing He, Peihao Chen, et al.
Science Translational Medicine|April 22, 2026
Phase separation-based HTS identifies cobimetinib as a YAP-TEAD inhibitor that suppresses hyperactivated YAP-induced cancer progressionRuizeng Yang, Liqiao Hu, Jing Wang, et al.
Pageof 2